This is good news IMO and the market likes it. ACTC is up a little in a very down market.
I love this line, Michael's expertise in pharmaceutical product development as well as experience in capital markets and deal-making will be invaluable to the company as we continue our forward momentum with our clinical programs. That is great, meaning they feel they will have a product and they know they will have to make a deal with big pharma
Geron is down not good, no news, no volume, no deal.
Good luck in this rigged casino,
No comments:
Post a Comment